Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0

The threat from invasive meningococcal disease (IMD) remains a serious source of concern despite the licensure and availability of vaccines. A limitation of current serogroup B vaccines is the breadth of coverage afforded, resulting from the capacity for extensive variation of the meningococcus and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidmos, Fadil A., Nadel, Simon, Screaton, Gavin R., Kroll, J. Simon, Langford, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055031/
https://www.ncbi.nlm.nih.gov/pubmed/30061891
http://dx.doi.org/10.3389/fimmu.2018.01621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055031/
https://www.ncbi.nlm.nih.gov/pubmed/30061891
http://dx.doi.org/10.3389/fimmu.2018.01621

Ejemplares similares